People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gatc Health Corp | — | Healthtech | Series B | $52.4M | $5.6M | 2021 |
| AnPac Bio-Medical Science Co., Ltd. | — | Biotechnology | Seed | $4.7M | $23.1M | 2020 |
Lin Yu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lin Yu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Moses | 1 | 5 |
| Dennis Locke | 1 | 4 |
| Robert Davidson | 1 | 3 |
| Rahul Gupta | 1 | 3 |
| Michael Manahan | 1 | 2 |
| Edward Tang | 1 | 2 |
| Gerry Martin | 1 | 2 |
| John Stroh | 1 | 2 |
| Gerald DeCiccio | 1 | 2 |
| He Yu | 1 | 1 |
| Ren Luo | 1 | 1 |
| Feng Guo | 1 | 1 |
| Sheng Liu | 1 | 1 |
| XueDong Du | 1 | 1 |
| Weidong Dai | 1 | 1 |
| Chang Yu | 1 | 1 |
| Sarah Yu | 1 | 1 |
| Jiefeng Gu | 1 | 1 |
| Yu Chris | 1 | 1 |
| Jayson Uffens | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.